Andreas Trumpp

Andreas Trumpp
Andreas Trumpp is full professor and heads the Division of Stem Cells and Cancer at the German
Cancer Research Center (DKFZ) and is founding director of the Heidelberg Institute for Stem Cell
Technology and Experimental Medicine (HI-STEM gGmbH). The Trumpp group explores the
principles of normal and diseased stem cell function and has a current focus on identifying and
overcoming mechanisms of therapy resistance at the molecular, genomic and single cell level studying
normal HSCs, AML, breast and pancreatic cancer. Several of the recent findings are currently
translated into investigator initiated clinical trials. Trumpp has published more than 200 publications,
has an H-Index of 75, holds an ERC Advanced Grant and belongs to the 1% most highly cited
researchers in 2022 (Clarivate)